EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research Quality of Clinical Trials Reported for Foods with Function Claims in Japan, 2023–2024: Evaluation Based on a Revised Tool to Assess Risk of Bias in Randomized Trials

Hiroharu Kamioka, Jun Kitayuguchi, Hideki Origasa, Kiichiro Tsutani

Nutrients · 2024

DOI: 10.3390/nu16162744 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Hiroharu Kamioka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Regional Environment Science, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku 156-8502, Tokyo, Japan. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Bias. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid for Scientific Research (C) from the Ministry of Edu-cation, Culture, Sports, Science and Technology (MEXT), Japan, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Foods with Function Claim was introduced in Japan in April 2015 to make more products available that are labeled with health functions. A product’s functionality of function claims must be explained by the scientific evidence presented in clinical trials (CTs) or systematic reviews, but the quality of recent CTs is unclear. The purpose of this study was to evaluate the risk of bias (RoB) using “a revised tool to assess risk (RoB 2)” published in 2018 for notifications based on all recent CTs published on the Consumer Affairs Agency website.

Methods

A total of 38 submitted papers based on CTs that were published on the Consumer Affairs Agency website during the period from 1 January 2023 to 30 June 2024 were eligible. The RoB 2 tool provides a framework for considering the risk of bias in the findings of any type of randomized trial. This tool with five domains was used to evaluate the quality of research methods.

Results

Eligible CTs were assessed as “low risk” (11%, n = 4), “medium risk” (13%, n = 5), and “high risk” (76%, n = 29). A number of highly biased papers were published. Bias occurred in all five domains, especially “bias in selection of the reported result (Domain 5)”, which was the most serious (“high risk”; 75%). For elements correlated with RoB, there was no significant difference (p = 0.785) in the RoB 2 score between for-profit and academic research in the author’s affiliated organization. There was no significant difference (p = 0.498) in the RoB score between the published year categories of 2000–2019 and 2020–2024, and no significant difference (p = 0.643) in the RoB score between English and Japanese language publications.

Conclusion

Overall, the quality of the latest CTs submitted after 2023 was very low, occurring in all five domains, and was most serious for “bias in selection of the reported result (Domain 5)”.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicBiasJapanHumansFunctional FoodFood LabelingResearch DesignRisk Assessment

Stichwörter der Autor:innen

clinical trialfunctionalityhealthy foodrandomized controlled trialrisk of bias

Autor:innen und Institutionen

  • Faculty of Regional Environment Science, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku 156-8502, Tokyo, Japan.
  • Physical Education and Medicine Research Center Unnan, 328 Uji, Unnan City 699-1105, Shimane, Japan.
  • Institute of Statistical Mathematic, 10-3 Midori-cho, Tachikawa City 190-8562, Tokyo, Japan.
  • The Institute of Seizon and Life Sciences, 4-5-1 Ginza, Chuo-ku 104-0061, Tokyo, Japan.

Förderung

  • Grant-in-Aid for Scientific Research (C) from the Ministry of Edu-cation, Culture, Sports, Science and Technology (MEXT), Japan
  • Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan

Zitieren

APA

Kamioka, H., Kitayuguchi, J., Origasa, H., & Tsutani, K. (2024). Research Quality of Clinical Trials Reported for Foods with Function Claims in Japan, 2023–2024: Evaluation Based on a Revised Tool to Assess Risk of Bias in Randomized Trials. Nutrients. https://doi.org/10.3390/nu16162744

Vancouver

Kamioka H, Kitayuguchi J, Origasa H, Tsutani K. Research Quality of Clinical Trials Reported for Foods with Function Claims in Japan, 2023–2024: Evaluation Based on a Revised Tool to Assess Risk of Bias in Randomized Trials. Nutrients. 2024. doi:10.3390/nu16162744

BibTeX
@article{Kamioka2024,
  author = {Kamioka, Hiroharu and Kitayuguchi, Jun and Origasa, Hideki and Tsutani, Kiichiro},
  title = {Research Quality of Clinical Trials Reported for Foods with Function Claims in Japan, 2023–2024: Evaluation Based on a Revised Tool to Assess Risk of Bias in Randomized Trials},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16162744}
}
Kostenlos starten →